Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Durham

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Human Pathology|December 22, 2018
Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISHMichael D Carter, Alison B Durham, Jayson R Miedema, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 12, 2020
Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and SafetyJohn E Hanks, Kevin J Kovatch, S Ahmed Ali, et al.
JAMA Dermatology|December 22, 2016
Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck MelanomaJeffrey S Moyer, Shannon Rudy, Philip S Boonstra, et al.
Journal of Medicinal Chemistry|October 5, 2022
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase InhibitorsRongjun He, Jifeng Wang, Zhi-Hong Yu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2020
DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approachAhmed K Alomari, Jayson R Miedema, Michael D Carter, et al.
Nature|August 21, 2020
Lymph protects metastasizing melanoma cells from ferroptosisJessalyn M Ubellacker, Alpaslan Tasdogan, Vijayashree Ramesh, et al.
Journal of Medicinal Chemistry|May 20, 2016
Use of Osmotic Pumps to Establish the Pharmacokinetic-Pharmacodynamic Relationship and Define Desirable Human Performance Characteristics for Aggrecanase InhibitorsMichael R Wiley, Timothy B Durham, Lisa A Adams, et al.
Journal of Medicinal Chemistry|November 22, 2014
Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritisTimothy B Durham, Valentine J Klimkowski, Christopher J Rito, et al.
Osteoarthritis and Cartilage|July 17, 2010
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAsC A Swearingen, M G Chambers, C Lin, et al.
Journal of Microscopy|May 1, 2015
Making EBSD on water ice routineD J Prior, K Lilly, M Seidemann, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Human Pathology|December 22, 2018
Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISHMichael D Carter, Alison B Durham, Jayson R Miedema, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 12, 2020
Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and SafetyJohn E Hanks, Kevin J Kovatch, S Ahmed Ali, et al.
JAMA Dermatology|December 22, 2016
Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck MelanomaJeffrey S Moyer, Shannon Rudy, Philip S Boonstra, et al.
Journal of Medicinal Chemistry|October 5, 2022
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase InhibitorsRongjun He, Jifeng Wang, Zhi-Hong Yu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2020
DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approachAhmed K Alomari, Jayson R Miedema, Michael D Carter, et al.
Nature|August 21, 2020
Lymph protects metastasizing melanoma cells from ferroptosisJessalyn M Ubellacker, Alpaslan Tasdogan, Vijayashree Ramesh, et al.
Journal of Medicinal Chemistry|May 20, 2016
Use of Osmotic Pumps to Establish the Pharmacokinetic-Pharmacodynamic Relationship and Define Desirable Human Performance Characteristics for Aggrecanase InhibitorsMichael R Wiley, Timothy B Durham, Lisa A Adams, et al.
Journal of Medicinal Chemistry|November 22, 2014
Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritisTimothy B Durham, Valentine J Klimkowski, Christopher J Rito, et al.
Osteoarthritis and Cartilage|July 17, 2010
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAsC A Swearingen, M G Chambers, C Lin, et al.
Journal of Microscopy|May 1, 2015
Making EBSD on water ice routineD J Prior, K Lilly, M Seidemann, et al.
Pageof 15